Anticipating the future of AI in health, pharma and more
With innovations in AI pointing to a future that often feels more science-fiction than fact what will be the full potential and impact of AI on the future of healthcare, pharma and the health sector as a whole. This next session of Enterprise Tuesday will discuss how far AI could go and the opportunities and risks this could generate for healthcare delivery, drug discovery, funding, collaborations, human/AI interfaces and more.
Chair David Weston, Senior Director of Emerging Innovations, AstraZeneca
Guest speakers:
- Hannah Sore, Co-Founder & CEO, PharmEnable
- Vincenzo Garzya, Strategic Planning & Operations leader. Chief of Staff, AstraZeneca
- Dr Roeland P.-J. E. Decorte, Founder & CEO, Decorte Future Industries Ltd.
Date:
Tuesday, 13 February, 2024 - 18:30 to 21:00
Event location:
Judge Business School, Trumpington St, Cambridge CB2 1AG
